Yüklüyor......
The pre-BCR to the rescue: therapeutic targeting of pre B cell ALL
Pre B-ALL is an aggressive cancer of the blood for which treatment of patients with relapsed and refractory disease remains a challenge (Bhatla et al., 2014). Here Geng et. al., surveyed activation status of the pre-B-cell receptor and comprehensively investigated downstream signaling mechanisms whi...
Kaydedildi:
| Yayımlandı: | Cancer Cell |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4532279/ https://ncbi.nlm.nih.gov/pubmed/25759017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2015.02.012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|